The bus is designed to expand access to lifesaving, next-generation treatments across nearly 70,000 square miles of underserved communities in South Texas.
The new "Advanced Therapies Bus" is equipped to perform both leukapheresis and stem cell collections on board. It is intended ...
Despite innovative new research, many cell and gene therapies do not make it all the way to the patients. Researchers and ...
Cell and gene therapy (CGT) has evolved from a niche research pursuit into a central force in biopharmaceutical innovation. By engineering living cells and genetic material to repair or replace faulty ...
Cell therapy manufacturers approach autologous therapy manufacturing in multiple ways, with point-of-care manufacturing, academic projects embedded within major medical centers, and centralized ...
GENEVA--(BUSINESS WIRE)--Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced it has acquired a majority interest in Aurion Biotech, Inc., ...
Hospitals are seeing success treating multiple myeloma with advanced therapies. Second autologous stem cell transplants, even ...
This article is authored by Amit Mookim, CEO, Immuneel Therapeutics Pvt. Ltd. and member, NATHEALTH.
Johnson & Johnson, the healthcare and lifestyle giant announced a more than $1 billion dollar investment in next generation ...
Cell therapy, one of the most promising frontiers in modern medicine, holds the potential to cure once-incurable diseases such as cancer and genetic disorders. But for all its promise, manufacturing ...